These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Genetic polymorphism of matrix metalloproteinase 9 and susceptibility to chronic obstructive pulmonary disease: A meta-analysis.
    Author: Yang X, Yu Y, Wang Y, Jiang W, Jiang W, Yin B.
    Journal: J Med Biochem; 2022 Jul 29; 41(3):263-274. PubMed ID: 36042908.
    Abstract:
    BACKGROUND: To systematically analyze the influence of genetic polymorphisms of matrix metalloproteinase 9 (MMP9) on susceptibility to chronic obstructive pulmonary disease (COPD). METHODS: Relevant literatures reporting MMP9 and susceptibility to COPD in PubMed, Web of Science, VIP, Wanfang and CNKI databases were searched using the key words "matrix metalloproteinases 9/MMP9, COPD/chronic obstructive pulmonary disease". Data of eligible literatures were extracted and analyzed for the odds ratio (OR) and corresponding 95% CI. RESULTS: A total of 16 independent studies reporting MMP9-1562C/T and COPD patients were enrolled and analyzed. None of the genetic models revealed the relationship between MMP9-1562C/T and susceptibility to COPD. Subgroup analyses identified lower risk of COPD in Chinese population carrying the TT genotype for theMMP9 rs3918242 relative to those carrying CT and CC genotypes (P=0.03, OR=0.67, 95% CI=0.46-0.97). CONCLUSIONS: Chinese population carrying the TT genotype for the MMP-9 rs3918242 present lower susceptibility to COPD relative to those carrying CT and CC genotypes. UVOD: Sistematska analiza uticaja genetskih polimorfizama matriks metaloproteinaze 9 (MMP9) na osetljivost hronične opstruktivne bolesti pluća (HOBP). METODE: Relevantna literatura koja izveštava o MMP9 i podložnosti HOBP u bazama podataka PubMed, Web of Scince, VIP, Wanfang i CNKI pretraživana je korišćenjem ključnih reči "matriks metaloproteinaze 9/MMP9, COPD/hronična opstruktivna bolest pluća". Podaci iz kvalifikovane literature su ekstrahovani i analizirani za odnos šanse (OR) i odgovarajući 95% CI. REZULTATI: Ukupno je uključeno i analizirano 16 nezavisnih studija koje su izveštavale o pacijentima sa MMP9-1562C/T i HOBP. Nijedan od genetskih modela nije otkrio vezu između MMP9-1562C/T i osetljivosti na HOBP. Analize podgrupa identifikovale su niži rizik od HOBP kod kineske populacije koja nosi TT genotip za MMP-9 rs3918242 u odnosu na one koji nose CT i CC genotipove (P=0,03, OR=0,67, 95% CI=0,46-0,97). ZAKLJUČAK: Kineska populacija koja nosi TT genotip za MMP9 rs3918242 predstavlja manju osetljivost na HOBP u odnosu na one sa CT i CC genotipovima.
    [Abstract] [Full Text] [Related] [New Search]